Table 1 Demographics and study characteristics in cancer patients receiving external pelvic radiotherapy with or without amifostine prophylaxis.

No of patients treated

44

21

23

Gender:

   Female

23

15

8

   Male

21

5

16

Age:

   Median (range)

63(34-79)

59

62

Tumor types:

   Rectal

20

7

13

   Cervical

12

8

4

   Prostate

5

2

3

   Bladder

3

1

3

   Endometrial

2

2

-

   Sarcoma

2

-

2

Mean radiation dose (Gy):

50.4

50.2